Skip to search formSkip to main contentSkip to account menu

Riluzole

Known as: 2-Amino-6-trifluoromethoxybenzothiazole, 2 Amino 6 trifluoromethoxybenzothiazole, 2-Amino-6-(trifluoromethoxy)benzothiazole 
A benzothiazole derivative with neuroprotective and potential anti-depressant and anxiolytic activities. While the mechanism of action of riluzole is… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Purpose: Alzheimer’s disease (AD) is a degenerative brain disorder and the major cause of dementia and cognitive deficits in the… 
2018
2018
Amyotroficka lateralni skleroza patři mezi progredujici neurodegeneativni onemocněni, jejiž prevalence s věkem stoupa. Dochazi k… 
2017
2017
Motor Neuron Disease (MND) is a progressive neurodegenerative disorder. It selectively damages the motor neurons and is currently… 
2004
2004
Summary.The exact types of pharmacodynamic interactions between riluzole and conventional antiepileptic drugs were evaluated in… 
Review
2001
Review
2001
Editor—In commenting on the National Institute for Clinical Excellence's guidance on riluzole Sandercock et al show the… 
2000
2000
The aim of the study is to present a computerized database of the Neurology department of Limoges University Hospital and the… 
Review
1999
Review
1999
BACKGROUND- Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease in adults and is a relatively… 
1997
1997
SummaryWe conducted a cost-benefit analysis of riluzole therapy in patients with amyotrophic lateral sclerosis (ALS; motor neuron…